These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22391032)

  • 1. Generation and exploration of new classes of antitubercular agents: The optimization of oxazolines, oxazoles, thiazolines, thiazoles to imidazo[1,2-a]pyridines and isomeric 5,6-fused scaffolds.
    Moraski GC; Markley LD; Chang M; Cho S; Franzblau SG; Hwang CH; Boshoff H; Miller MJ
    Bioorg Med Chem; 2012 Apr; 20(7):2214-20. PubMed ID: 22391032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2.
    Lu X; Liu X; Wan B; Franzblau SG; Chen L; Zhou C; You Q
    Eur J Med Chem; 2012 Mar; 49():164-71. PubMed ID: 22264895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatives of 3-isoxazolecarboxylic acid esters: a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Pieroni M; Franzblau SG; Bishai WR; Kozikowski AP
    Curr Top Med Chem; 2012; 12(7):729-34. PubMed ID: 22283815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB; Shinde AU; Babar DA; Sangu KG; Vagolu SK; Eruva VK; Jadav SS; Misra S; Dharmarajan S; Rode HB
    Arch Pharm (Weinheim); 2021 Oct; 354(10):e2000419. PubMed ID: 34185337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 2-(2-benzylidenehydrazinyl)benzo[d]thiazole as potential antitubercular agents.
    Bairwa VK; Telvekar VN
    Comb Chem High Throughput Screen; 2013 Mar; 16(3):244-7. PubMed ID: 23176058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.
    Moraski GC; Seeger N; Miller PA; Oliver AG; Boshoff HI; Cho S; Mulugeta S; Anderson JR; Franzblau SG; Miller MJ
    ACS Infect Dis; 2016 Jun; 2(6):393-8. PubMed ID: 27627627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases.
    Thompson AM; Blaser A; Palmer BD; Anderson RF; Shinde SS; Launay D; Chatelain E; Maes L; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2583-2589. PubMed ID: 28462832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
    Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.
    Moraski GC; Bristol R; Seeger N; Boshoff HI; Tsang PS; Miller MJ
    ChemMedChem; 2017 Jul; 12(14):1108-1115. PubMed ID: 28654200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fused heterocycles: synthesis of some new imidazo[1,2-a]- pyridine derivatives.
    Kasimogullari BO; Cesur Z
    Molecules; 2004 Sep; 9(10):894-901. PubMed ID: 18007490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis.
    Meissner A; Boshoff HI; Vasan M; Duckworth BP; Barry CE; Aldrich CC
    Bioorg Med Chem; 2013 Nov; 21(21):6385-97. PubMed ID: 24075144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters.
    Moraski GC; Chang M; Villegas-Estrada A; Franzblau SG; Möllmann U; Miller MJ
    Eur J Med Chem; 2010 May; 45(5):1703-16. PubMed ID: 20116900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M
    Eur J Med Chem; 2001 Sep; 36(9):743-6. PubMed ID: 11672884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents.
    Kang S; Kim YM; Jeon H; Park S; Seo MJ; Lee S; Park D; Nam J; Lee S; Nam K; Kim S; Kim J
    Eur J Med Chem; 2017 Aug; 136():420-427. PubMed ID: 28527405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitubercular activity of new mefloquine-oxazolidine derivatives.
    Gonçalves RS; Kaiser CR; Lourenço MC; de Souza MV; Wardell JL; Wardell SM; da Silva AD
    Eur J Med Chem; 2010 Dec; 45(12):6095-100. PubMed ID: 20932608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.